New movement in Parkinson's.
Lozano
Andres M
AM
Toronto Western Hospital, University of Toronto.
Kalia
Suneil K
SK
D000375:Aging; D000978:Antiparkinson Agents / Q000627:therapeutic use; D016923:Cell Death; D004298:Dopamine / Q000096:biosynthesis; D004558:Electric Stimulation; D051100:Glial Cell Line-Derived Neurotrophic Factor; D006801:Humans; D018832:Molecular Chaperones / Q000502:physiology; D009154:Mutation; D009414:Nerve Growth Factors / Q000627:therapeutic use; D009419:Nerve Tissue Proteins / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D009474:Neurons / Q000378:metabolism / Q000473:pathology; D010300:Parkinson Disease / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology / Q000628:therapy*; D046988:Proteasome Endopeptidase Complex / Q000502:physiology; D017510:Protein Folding; D013378:Substantia Nigra / Q000473:pathology / Q000503:physiopathology; D051843:Synucleins; D025801:Ubiquitin / Q000502:physiology; D044767:Ubiquitin-Protein Ligases / Q000235:genetics
D000978:Antiparkinson Agents; C495039:GDNF protein, human; D051100:Glial Cell Line-Derived Neurotrophic Factor; D018832:Molecular Chaperones; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins; D051843:Synucleins; D025801:Ubiquitin; D044767:Ubiquitin-Protein Ligases; C111567:parkin protein; D046988:Proteasome Endopeptidase Complex; D004298:Dopamine